Literature DB >> 9048342

Immunohistochemical localization of IL-8 and TGF-beta in streptococcal glomerulonephritis.

S Mezzano1, M E Burgos, F Olavarría, I Caorsi.   

Abstract

Acute poststreptococcal glomerulonephritis (APSGN) is characterized by diffuse glomerular hypercellularity, primarily as a result of accumulation of neutrophils (exudative glomerulonephritis), increase in intrinsic glomerular cells, and transient pathological mesangial matrix expansion. Cytokines and growth factors are supposed to play an important role as mediators of inflammation and as progression factors in various renal disorders. Interleukin-8 is a recently described cytokine, defined as a selective activator and chemoattractant of polymorphonuclear leukocytes (PMNL) and transforming growth factor (TGF)-beta plays a central role in the accumulation of pathological extracellular matrix in glomerulonephritis. This study analyzed the biopsies of ten patients with APSGN, using immunohistochemistry (avidin-biotin complex/horseradish peroxidase method) using monoclonal antibodies anti-IL-8, anti-TGF-beta 1, beta 2, beta 3. Controls consisted of non-immune mouse serum, or anti-TGF-beta preabsorbed with human recombinant TGF-beta. Compared with normal renal tissue, and minimal change disease, an increased glomerular IL-8 and TGF-beta staining was observed in all of the biopsies. Furthermore, in one patient, we observed a weak deposit of TGF-beta in tubulointerstitium. Immunoreactive IL-8 and TGF-beta in glomeruli was correlated with light microscopic and clinical features. There was a significant association (P < 0.05), between IL-8 glomerular immunoreactivity and neutrophil infiltration and between TGF-beta glomerular staining and mesangial matrix expansion. Otherwise, there was no correlation with the mesangial cellularity. It was concluded that increased protein expression of IL-8 and TGF-beta are observed in APSGN and may play a role in the acute glomerular inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048342     DOI: 10.1681/ASN.V82234

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.

Authors:  Markus Wörnle; Holger Schmid; Bernhard Banas; Monika Merkle; Anna Henger; Maximilian Roeder; Simone Blattner; Elisabeth Bock; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection.

Authors:  Beinan Wang; Thamotharampillai Dileepan; Sarah Briscoe; Kendra A Hyland; Johnthomas Kang; Alexander Khoruts; P Patrick Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

3.  Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis.

Authors:  Nesrin Besbas; Fatih Ozaltin; Ferhat Catal; Seza Ozen; Rezan Topaloglu; Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

4.  Streptococcal exotoxin B increases interleukin-6, tumor necrosis factor alpha, interleukin-8 and transforming growth factor beta-1 in leukocytes.

Authors:  Ninoska Viera; Adriana Pedreanez; Jaimar Rincon; Jesus Mosquera
Journal:  Pediatr Nephrol       Date:  2007-05-25       Impact factor: 3.714

5.  Streptococcal modulation of cellular invasion via TGF-beta1 signaling.

Authors:  Beinan Wang; Shaoying Li; Peter J Southern; Patrick P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

6.  Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.

Authors:  Sang-Youb Han; Chun-Gyoo Ihm; Dae-Ryong Cha; Young-Sun Kang; Kum-Hyun Han; Hyoung-Kyu Kim; Jee-Young Han
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.